DSG1 and acquired polycythemia vera: More important for the future use of the Dsg1/3-specific adsorbers in the treatment of PV patients is our observation that PV IgG fractions depleted from anti-Dsg1/3 reactivity did not induce skin lesions when injected into neonatal mice.